OQRO

Feed News

Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

CFO exercised or converted 7,787 HIMS derivative securities | OQRO

Home
Insider trades
Hims & Hers Health
CFO exercised or converted 7,787 HIMS derivative securities

Insider trades

Insider trade

CFO exercised or converted 7,787 HIMS derivative securities

Traded Oct 3, 2025 · Filed Oct 7, 2025

HIMHims & Hers HealthHIMS

7,787
Shares · @ $5.01

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Oct 3, 2025
Reporting period: Not applicable
Filed with the SEC: Oct 7, 2025

CFOOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001773751-25-000335

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Filed / recorded

Oct 7, 2025, 8:47 PM UTC

Added to OQRO

Oct 6, 2026, 7:59 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

Hims & Hers Health, Inc.

Issuer CIK

1773751

Ticker

HIMS

Reporting person

Oluyemi Okupe

Relationship

Officer

Officer title

Chief Financial Officer

Security

Class A Common Stock

Table

Non-derivative (Table I)

Transaction date

Oct 3, 2025

Transaction code

Shares / units

7,787

Price per share

$5.01

Acquired / disposed

Acquired (A)

Shares owned after

78,019

Ownership form

Direct

Amendment

Footnotes from the filing

The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 21, 2025 by the Reporting Person.

Around the same time

Soleil Boughton (Chief Legal Officer) sold ~$132K of Hims & Hers Health

Scheduled in advanceFiled 11mo ago

Oluyemi OkupeChief Financial Officer

Filed 12mo ago

7,785Shares · @ $5.01

Traded Oct 17, 2025 · filed 3 days later

Derivative exercise or conversion — not an open-market buy.

More Official record

Oluyemi OkupeChief Financial Officer

Filed 12mo ago

3,807Shares · @ $11.53

Traded Oct 17, 2025 · filed 3 days later

Derivative exercise or conversion — not an open-market buy.

More Official record